As December 2025 draws to a close, the SARS-CoV-2 XFG variant—nicknamed "Stratus"—has surged to dominate 69% of U.S. cases, driven by seven key mutations enabling immune evasion. This real-time analysis maps the variant's spread, symptoms, and vaccine effectiveness, offering actionable insights for the 2026 season.
Read More